默沙东ADC数据亮眼，H.C. Wainwright下调Summit至中性
受竞争对手默沙东(122.41, 6.53, 5.64%)联合科伦博泰的抗体偶联药物sac-TMT在肺癌领域取得积极III期临床结果影响，H.C． Wainwright于5月22日决定将Summit Therapeutics的评级由买入调整为中性，同时撤销了原先设定的23美元目标价。 本次评级调整的主因，是H.C． Wainwright对sac-TMT数据可能对Summit核心产品ivonescimab构成的竞争压力深感忧虑。依据ASCO 2026年会披露的摘要，sac-TMT联合Keytruda作为PD
summer travel costs surge, low-income consumers may stay home
Download the Sina Finance app to track global exchange rates in real-time Amid rising inflation from Iran's geopolitical conflict and increasing travel expenses, this summer may witness another wave of staycations. Market Analysis According to a recent co
UK to Host Video Summit on Strait of Hormuz Crisis
The UK is set to host a video summit today to address the issue of the Strait of Hormuz, with representatives from 35 countries attending to evaluate diplomatic and political solutions for reopening this crucial waterway.